Intimation of Analyst /Institutional Investors Meeting

Ref: ADL/SE/2026-27/35 August 4, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Bandra - Kurla Complex, Bandra Dalal Street, (E), Mumbai – 400051 Mumbai – 400 001 NSE SYMBOL: AARTIDRUGS BSE CODE – 524348 Dear Sir/Madam, Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sub: Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors (Participants) as per the details below. Date & Time Nature of Meeting Organised by Venue 10th August 2026 1x1/ Group Meeting Nirmal Bang Trident BKC, Mumbai 11:00 AM to 1:00 PM Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company. This is for your information and records. Yours faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: F12932